The US Food and Drug Administration dropped its complaint against fitness tracker maker Whoop Inc. over its blood-pressure tracking tool, marking an about-face after the agency initially asked the company to disable it, according to Bloomberg.
The US Food and Drug Administration dropped its complaint against fitness tracker maker Whoop Inc. over its blood-pressure tracking tool, marking an about-face after the agency initially asked the company to disable it, according to Bloomberg.